"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
Rescula Patient Information including How Should I Take
In this Article
- What is unoprostone ophthalmic (Rescula)?
- What are the possible side effects of unoprostone ophthalmic (Rescula)?
- What is the most important information I should know about unoprostone ophthalmic (Rescula)?
- What should I discuss with my health care provider before using unoprostone ophthalmic (Rescula)?
- How should I use unoprostone ophthalmic (Rescula)?
- What happens if I miss a dose (Rescula)?
- What happens if I overdose (Rescula)?
- What should I avoid while using unoprostone ophthalmic (Rescula)?
- What other drugs will affect unoprostone ophthalmic (Rescula)?
- Where can I get more information?
What should I discuss with my health care provider before using unoprostone ophthalmic (Rescula)?
Do not use this medication if you are allergic to unoprostone.
Before using unoprostone, tell your doctor if you are allergic to any drugs, or if you have swelling or infection of your eye.
Unoprostone ophthalmic may cause a gradual change in the color of your eyes or eyelids and lashes, as well as increased growth or thickness of your eyelashes. These color changes, usually an increase in brown pigment, occur slowly and you may not notice them for months or years. Color changes may be permanent even after your treatment ends, and may occur only in the eye being treated. This could result in a cosmetic difference in eye or eyelash color from one eye to the other.
FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether unoprostone passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I use unoprostone ophthalmic (Rescula)?
Do not use this medication while you are wearing contact lenses. This medication may contain a preservative that can be absorbed by soft contact lenses. Wait at least 15 minutes after using unoprostone before putting your contact lenses in.
Use this medication exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor. Follow the instructions on your prescription label.
Wash your hands before using the eye drops.
To apply the eye drops:
- Tilt your head back slightly and pull down on the lower eyelid to create a small pocket. Hold the dropper above the eye with the dropper tip down. Look up and away from the dropper. Squeeze out a drop and close your eye. Gently press your finger to the inside corner of the eye (near the nose) for about 1 minute to keep the liquid from draining into your tear duct.
- If you use more than one drop in the same eye, wait about 5 minutes before putting in the next drop. Also wait at least 5 minutes before using any other eye drops that your doctor has prescribed.
Do not allow the dropper to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.
At any time during your use of unoprostone ophthalmic, tell your doctor at once if you have an eye injury, if you develop an eye infection, or if you plan to have eye surgery.
Do not use the eye drops if the liquid changes colors or has particles in it.
Store the drops at room temperature away from moisture, heat, and light. Keep the bottle tightly closed when not in use.
Additional Rescula Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.